Yazar "Guclu, Salih Zeki" seçeneğine göre listele
Listeleniyor 1 - 6 / 6
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Afatinib (A) vs erlotinib (E) as second-line therapy of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following platinum-based chemotherapy: Overall survival (OS) analysis from the global phase III trial LUX-Lung 8 (LL8).(Amer Soc Clinical Oncology, 2015) Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos N.; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Zeki; Morabito, Alessandro; Min, Young Joo; Ardizzoni, Andrea; Gadgeel, Shirish M.; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.Öğe Afatinib (A) vs erlotinib (E) as second-line therapy of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following platinum-based chemotherapy: Overall survival (OS) analysis from the global phase III trial LUX-Lung 8 (LL8).(Amer Soc Clinical Oncology, 2015) Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos N.; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Zeki; Morabito, Alessandro; Min, Young Joo; Ardizzoni, Andrea; Gadgeel, Shirish M.; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.Öğe Afatinib (A) vs erlotinib (E) as second-line therapy of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following platinum-based chemotherapy: Overall survival (OS) analysis from the global phase III trial LUX-Lung 8 (LL8).(Amer Soc Clinical Oncology, 2015) Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos N.; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Zeki; Morabito, Alessandro; Min, Young Joo; Ardizzoni, Andrea; Gadgeel, Shirish M.; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.Öğe Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.(Amer Soc Clinical Oncology, 2015) Gadgeel, Shirish M.; Dols, Manuel Cobo; Felip, Enriqueta; Soria, Jean-Charles; Lee, Ki Hyeong; Lu, Shun; Georgoulias, Vassilis; Fulop, Andrea; Goker, Erdem; Syrigos, Konstantinos N.; Morabito, Alessandro; Coskun, Hasan Senol; Guclu, Salih Zeki; Li, Wei; Popat, Sanjay; Ardizzoni, Andrea; Lungershausen, Juliane; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.Öğe Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.(Amer Soc Clinical Oncology, 2015) Gadgeel, Shirish M.; Dols, Manuel Cobo; Felip, Enriqueta; Soria, Jean-Charles; Lee, Ki Hyeong; Lu, Shun; Georgoulias, Vassilis; Fulop, Andrea; Goker, Erdem; Syrigos, Konstantinos N.; Morabito, Alessandro; Coskun, Hasan Senol; Guclu, Salih Zeki; Li, Wei; Popat, Sanjay; Ardizzoni, Andrea; Lungershausen, Juliane; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.Öğe Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.(Amer Soc Clinical Oncology, 2015) Gadgeel, Shirish M.; Dols, Manuel Cobo; Felip, Enriqueta; Soria, Jean-Charles; Lee, Ki Hyeong; Lu, Shun; Georgoulias, Vassilis; Fulop, Andrea; Goker, Erdem; Syrigos, Konstantinos N.; Morabito, Alessandro; Coskun, Hasan Senol; Guclu, Salih Zeki; Li, Wei; Popat, Sanjay; Ardizzoni, Andrea; Lungershausen, Juliane; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.
